In today's world, Navacaprant has gained great importance in various aspects of daily life. Both on a personal and professional level, Navacaprant has left a significant mark, generating debates and reflections around his impact on society. From its origins to its present day, Navacaprant has become a topic of interest that arouses curiosity and wonder. In this article, we will explore the different dimensions of Navacaprant and analyze its influence in various contexts, providing a complete overview of this topic of current relevance.
Clinical data | |
---|---|
Other names | BTRX-140; CYM-53093; NMRA-140; NMRA-335140 |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C25H32FN5O2 |
Molar mass | 453.562 g·mol−1 |
3D model (JSmol) | |
| |
|
Navacaprant (developmental code names include BTRX-335140, BTRX-140, CYM-53093, NMRA-335140, and NMRA-140), is a selective κ-opioid receptor antagonist which is under development for the treatment of major depressive disorder. As of December 2023, navacaprant is in phase 3 clinical trials for this indication.